Form 4 for TXMD TherapeuticsMD, Inc.
Accepted 2021-08-18 00:00:00 ET · period of report 2021-08-16 · accession 0001387131-21-008680 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-18 | 2021-08-16 | TXMD | BISARO PAUL | Dir | P - Purchase | $0.79 | +50.0K | 196.9K | +34% | +$39.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-16 | P | A | 50,000 | $0.79 | 196,864 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. The reported securities were purchased in multiple transactions with prices ranging from $0.786 to $0.79 for an average weighted purchase price of $0.79. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |